Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism

Gynecological Endocrinology

Volumn 14, Issue 6, 2000, Pages 411-416

  De Leo, V ^a   Fulghesu, A M ^a   La Marca, A ^a   Morgante, G ^a   Pasqui, L ^a   Talluri, B ^a   Torricelli, M ^a   Caruso, A ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Combined Oral Contraceptive; Cyproterone Acetate; Flutamide; GnRH Agonist; Hirsutism; Polycystic Ovary Syndrome

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTENEDIONE; ESTRADIOL; ESTRONE; FLUTAMIDE; FOLLITROPIN; GONADORELIN AGONIST; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PRASTERONE SULFATE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HIRSUTISM; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0034474315     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513590009167712     Document Type: Article

References (22)

1. The polycystic ovary syndrome
2. Pathogenesis and treatment of polycystic ovary syndrome
3. Polycystic ovarian disease
4. The polycystic ovary syndrome: Pathogenesis and treatment
5. Ovarian, adrenal and peripheral testosterone levels in the polycystic ovary syndrome
6. Hypothalamo-pituitary-adrenal axis and adrenal function before and after ovariectomy in premenopausal women
7. A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome
8. Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin)
9. Endocrine therapy of hyperandrogenism
10. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism
11. Steroid contraception
12. Treatment of moderate and severe hirsutism by gonadotropin-releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirutism
13. The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatile releases distinguishes adrenal from ovarian hyperandrogenism
14. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial
15. Hormonal effects of flutamide in young women with polycystic ovary syndrome
16. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin relesing factor (CRF)
17. Hirsutism: Implications, etiology, and management
18. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: A clinical research center study
19. Clinical and hormonal effects of goandotropin-releasing hormone agonist plus an oral contraceptive in severely hirsute patients with polycystic ovary syndrome
20. Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary syndrome
21. Microsomial effects of cyproterone acetate and flutamide in rat testis
22. Flutamide, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer